Evidence map›Paper›PMID 36012334›Full record

ArticleInternational journal of molecular sciences2022

A New Method of Myostatin Inhibition in Mice via Oral Administration of

Dong Kyung Sung, Hyeongseop Kim, Sang Eon Park, Jiwon Lee, Ju-A Kim, Young-Chul Park, Hong Bae Jeon, Jong Wook Chang, Jeehun Lee

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Myostatin inhibition with orally administeredFrontiers in neurology · 2025
    Article
  2. Review
  3. New Pharmacological Approaches for Rare Diseases.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Dong Kyung SungDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Hyeongseop KimStem Cell Institute, ENCell Co., Ltd., Seoul 06072, Korea.ORCID 0000-0001-8546-6472
Sang Eon ParkStem Cell Institute, ENCell Co., Ltd., Seoul 06072, Korea.ORCID 0000-0003-3315-6426
Jiwon LeeDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.ORCID 0000-0002-8456-684X
Ju-A KimDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Young-Chul ParkBL Corporation, Yongin-si 16827, Korea.
Hong Bae JeonStem Cell Institute, ENCell Co., Ltd., Seoul 06072, Korea.
Jong Wook ChangStem Cell Institute, ENCell Co., Ltd., Seoul 06072, Korea.
Jeehun LeeDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Samsung Medical Center · KRCell Biotech (South Korea) · KR

Funding

Korea Health Industry Development Institute HI15C2142Samsung Medical Center SMX1220051Seoul R&BD Program BT200044
6 · The paper itself

Abstract

Myostatin is a member of the transforming growth factor-beta superfamily and is an endogenous negative regulator of muscle growth. This study aimed to determine whether an oral administration of

Indexed as

Lacticaseibacillus caseiMuscular Dystrophy, AnimalMuscular Dystrophy, DuchenneAdministration, OralAnimalsAntibodiesDisease Models, AnimalHumansMiceMice, Inbred mdxMuscle, SkeletalAntibodiesDuchenne muscular dystrophyLactobacillus caseimdx mousemyostatinpoly-gamma-glutamic acid synthetase A

Identifiers

PMID36012334
PMCPMC9409196
OpenAlexW4291465543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.